ArthNow Logo
ArthNow
•3 min read•
✦Reported by Moneycontrol.com

It's not made for India: Deepinder Goyal addresses criticism on Temple's 'too high' price

It's not made for India: Deepinder Goyal addresses criticism on Temple's 'too high' price
Source: Moneycontrol.com

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓Deepinder Goyal addressed criticism regarding the high price of his new AI-powered wellness device, Temple.
  • ✓He said, "Temple is not made for India.
  • ✓It's made for the world." Goyal clarified that the product is for global consumers and not a medical tool, urging people to wait for user reviews.

Story at a Glance

Category
Indian Markets
Reported By
Moneycontrol.com
Reading Speed
3 Minute(s)
Market Focus
India Economy

Deepinder Goyal, founder of Eternal, has responded to criticism surrounding the pricing and claims of the company's newly launched AI-powered wellness device, Temple, saying the product is primarily aimed at global consumers and not the Indian market.

In a lengthy post on X following a wave of online debate, Goyal defended Temple's pricing, scientific approach and positioning, while clarifying that the device is not intended to replace medical care.

"Temple is not made for India. It's made for the world," Goyal wrote. "We don't expect any more than 1 percent of Temples being sold in India."

The statement comes after social media users questioned the device's steep price tag and scrutinised claims around its brain-monitoring features.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

Moneycontrol.com

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.